Lumina 3D
TIME's Best Inventions award-winning 3D visualization
Software · Cloud SaaSCompany source
Company profile
About iSchema View
RapidAI is a leading clinical AI platform company that delivers deep clinical decision support across multiple disease states and specialties. The company's Rapid Enterprise Platform connects intelligence, workflow, and care teams across health systems, providing AI-driven insights for neurovascular conditions (stroke, hemorrhage, aneurysm), cardiac and vascular diseases (aortic conditions, pulmonary embolism), and radiology workflows. RapidAI goes beyond simple anomaly detection to provide comprehensive clinical capabilities including triage, localization, quantification, characterization, visualization, and longitudinal tracking. The platform serves over 2,500 hospitals across 100+ countries, processing more than 20,000 daily scans. With 30 FDA-cleared modules and backed by extensive clinical validation including 750+ publications, 25+ clinical trials, and 11 New England Journal of Medicine publications, RapidAI has established itself as a clinically rigorous solution. The company's mobile app enables real-time collaboration and alerts for urgent cases, while its Navigator Pro and Rapid Insights tools provide imaging prioritization and custom performance analytics. RapidAI's approach emphasizes deep expertise in critical disease states rather than broad surface-level detection, equipping clinicians with actionable insights that drive meaningful patient outcomes while improving operational efficiency and financial viability for healthcare organizations.
Company description iSchema View official website
Primary marketMedical Imaging & Radiology
Commercial modelCommercial information available on request
Company presenceOfficial website
Work at iSchema View?
Claim this listing Claim this profile to manage Company information and connect with the Health AI Central audience.
01 · Operating footprint
Where the Company operates
Company-profile context for clinical focus, customers, deployment, integration, milestones, and partnerships.
Clinical focus
- Aortic conditions
- Brain aneurysm
- Cardiac conditions
- Hemorrhagic stroke
- Ischemic stroke
- Medium vessel occlusion
- Neurovascular conditions
- Pulmonary embolism
- Vascular diseases
Who it serves
- Care Teams
- Health Systems
- Hospital Administrators
- Hospitals
- IT departments
- Physicians
- Radiology departments
Deployment & integration
Cloud Saas · Hybrid deployment with recorded integration context.
Recorded integration context: DICOM viewers, EMR systems, Third-party healthcare ecosystem interoperability framework.
Geographic context
Markets100+ countries globally · Multi-state US presence
Company sourceOfficial website
Company milestones
Platform expansion
Lumina 3D named to TIME's Best Inventions list. Frost & Sullivan 2026 Radar ranked RapidAI as leader with 4.8/5.0 innovation score, ahead of 96% of industry. Platform expansion into cardiac, vascular, and radiology beyond neurovascular origins.
Partnerships
Recorded partners
- Leading healthcare organizations (unnamed)
- Stanford University (co-founder affiliation)
02 · Flagship portfolio
Products, workflows, and platform capabilities
Selected source-backed Company products and the available commercial context.
Navigator Pro
Imaging prioritization and AI decision support for Radiology
Software · Cloud SaaSCompany source
Rapid Aneurysm
Surface silent risks—track change and guide smarter intervention
Software · Cloud SaaSCompany source
Rapid Aortic
Find and track more aortic patients
Software · Cloud SaaSCompany source
Rapid Enterprise Platform
Enterprise clinical AI platform connecting intelligence, workflow, and teams across health systems
Platform · HybridCompany source
Rapid Hemorrhagic
AI-driven bleed assessment for faster treatment decisions
Software · Cloud SaaSCompany source
Rapid Insights
Custom performance analytics platform
Platform · Cloud SaaSCompany source
Rapid Ischemic Stroke
AI-driven stroke triage from detection to destination
Software · Cloud SaaSCompany source
Rapid Mobile App
Real-time collaboration and alerts for urgent cases
Software · Cloud SaaSCompany source
03 · Research intelligence
Research Intelligence evidence
Publications, preprints, clinical validation, and regulatory records in Evidence Position order.
Evidence position
Publications, clinical validation, and regulatory records connected to this Company appear here.
Research
Publications & preprints
No linked records are currently available.
Clinical validation
Clinical-trial records
No linked records are currently available.
Regulatory
Regulatory records
RapidK233582 · 510k · Apr 22, 2024
Rapid RV/LVK223396 · 510k · Feb 1, 2023
RapidK213165 · 510k · Feb 8, 2022
04 · Company-reported outcomes
Outcomes and case studies
Company-reported outcomes and customer stories are distinct from linked Research Intelligence evidence.
2,500+ hospitals deployed
Global deployment scale
100+ countries
Geographic reach
20,000+ daily scans
Processing volume
Doubles EVT treatment rates
CT perfusion for stroke patients
No increase in treatment delays
Adding CTP to stroke imaging workflows
Multi-state registry study participants
Adding CT perfusion to routine stroke imaging to identify more treatable stroke patients
More than doubled EVT rates with no increase in treatment delays
05 · Leadership
Leadership team
Leadership profiles and professional links from the current Company record.
Greg Albers
Co-Founder
David Stoffel
Chief Business Officer
06 · Company updates
Updates from iSchema View
Recent articles published on iSchema View's official website.
Why aortic surveillance fails without automated tracking
Read on iSchema ViewChest imaging: How aortic pathology hides in plain sight
Read on iSchema ViewMedical imaging AI and the future of neurosurgery
Read on iSchema ViewBeyond triage: What a truly unified radiology workspace looks like
Read on iSchema ViewHow AI is turning imaging into a lifelong surveillance tool
Read on iSchema View07 · HAIC coverage
Coverage and analysis
Health AI Central reporting that mentions this Company.
No HAIC coverage is currently linked to this Company.
08 · Official presence
Company sources and channels
Curated official destinations from the active Company record.
09 · Market pathway
Additional Companies in this Market
Other active Companies in the same market, selected alphabetically from the HAIC directory.
Market context
Medical Imaging & Radiology
Companies that apply AI to analyze medical images for diagnostic purposes, workflow optimization, or clinical decision support. Covers general radiology (X-rays, CT scans, MRIs, ultrasounds) across multiple organ systems, as well as specialized imaging in ophthalmology and dermatology.
Explore the full market directory or compare this Company with additional active profiles.
View all Companies in this market
10 · Pro research
Coming soon
Expanded Company research is in development.
Health AI Central Pro · Coming Soon
Deeper Company research is coming soon.
Pro Research will introduce expanded technical context, linked evidence analysis, and comparative Company research.
Linked research, clinical, and regulatory source pathways.
Expanded product, deployment, integration, and partnership research.
Record-level provenance and review context.